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http://dxObjective: The right ventricle (RV) demonstrates differential adaptations in response to pressure versus volume
loading, a phenomenon that may be important in the management of children and adults with congenital heart
disease (CHD). The purpose of this study is to elucidate possible transcriptional mechanisms of the RV response
to pressure versus volume loading in vivo.
Methods: Fetal lambs had aortopulmonary shunting or pulmonary artery (PA) banding. Four weeks after
spontaneous delivery, ovine hearts were evaluated for hemodynamic changes and changes in expression of sar-
comeric gene proteins and transcriptional factors. Western blot densitometry and chromatin immunoprecipita-
tion were applied using standard techniques. Transactivation assays were performed using transient
transfections in Schneider’s Drosophila line 2 cells in culture.
Results: After PA banding, the RV pressure increased from 36  4 mm Hg (n ¼ 4) to 96  8 mm Hg (n ¼ 4,
P<.05). The RVs of shunted and banded animals showed significant increases in the expression levels and pro-
moter binding of activators myocyte enhancer factor 2, GATA-4, Nkx2.5, transcriptional enhancer factor 1, and
specificity protein (Sp) 1. The transcriptional repressor Sp3 was downregulated in shunted animals, but its ex-
pression was increased paradoxically in the RVof the PA band group. Immunoprecipitation of Sp3 showed post-
translational modification to the acetylated isoform. In transient transfections of Schneider’s Drosophila line 2
cells, acetylation of Sp3 converted it from a transcriptional repressor to an activator.
Conclusions: Posttranslational modifications of the transcriptional repressor Sp3, by acetylation, may be an im-
portant mechanism in the differential response of the RV to abnormal loading conditions. Sp3may serve as a bio-
marker for RV failure for various heart defects in children and adults with CHD. These findings may have
therapeutic implications in the management of right heart failure. (J Thorac Cardiovasc Surg 2013;145:1335-44)E
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SThe transcriptional regulation of cardiac differentiation, hy-
pertrophy, and heart failure has important implications for
the development of cell-based or pharmacologic treatment
of myocardial disease.1,2 We have shown previously in
a shunted fetal lamb model of congenital heart disease
and pathologic hypertrophy that transcription factors are
modulated in a predictable way.3,4 In this model,
sarcomeric gene expression follows a pathologic
hypertrophic program that recapitulates fetal expression
patterns and represents an early milestone of heart failure.
Myocardial transactivators are upregulated whereas
repressors are downregulated. It has been postulated that
a final common pathway to heart failure exists at
a transcriptional level.5-8 This transcriptional disorder ine Departments of Surgerya and Pediatrics,b University of California at San
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The Journal of Thoracic and Carthe heart may be a target for pharmacotherapy of cardiac
hypertrophy and dysfunction.
In the current study, we sought to extend our observations
and validate the hypothesis of transcriptional convergence
on the road to cardiac hypertrophy and heart failure. We
have developed a clinically relevant model of right ventric-
ular pressure load in lambs by placing pulmonary artery
(PA) bands in utero. The increased afterload causes severe
right ventricular hypertrophy. The regulation of transcrip-
tion factors in this model confirms many of our observations
in the ovine model of cardiac volume loading. However,
there appears to be a divergence in the regulation and post-
translational modifications of specificity protein (Sp) 3,
a member of the Sp1 family of transcription factors, which
is critical to the assembly of the basal transcriptional com-
plex as well as comprehensive regulation of the network of
cardiac gene expression.
Right ventricular function is critical to the outcomes of
patients with congenital heart disease, especially those
with chronic left-to-right shunting (patent ductus arteriosus,
atrial septal defect, ventricular septal defect, AV canal, and
so on), right heart valvular insufficiency (repaired tetralogy
of Fallot with pulmonary insufficiency, tricuspid regurgita-
tion, Ebstein’s anomaly), single-ventricle disorders, con-
genitally corrected transposition of the great arteries,
atrially repaired D-transposition of the great arteries, anddiovascular Surgery c Volume 145, Number 5 1335
TABLE 1. Heart mass in 4-week-old lambs
Cardiac
chamber
PA Band Shunt
Control PA Band P value Control Shunt P value
RA 2.2  0.4 4.3  0.4 .003 2.9  1.9 5.8  1.6 .001
LA 1.7  0.4 3.5  0.7 .002 1.8  0.3 8  2 .001
RV 10.8  0.7 29.7  2.6 .007 12.6  3 25.5  7.7 .003
LV 22  2.5 31  4 .07 20  1.8 33  5 .003
Septum 9.5  2.7 17.8  4.3 .001 9.5  3 18  2 .0002
Total 44  5 104  30 .001 36  6.5 113  34 .0001
Values in grams are represented as mean standard deviation. PA, Pulmonary artery;
RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle.
Abbreviations and Acronyms
BNP ¼ brain natriuretic peptide
HAT ¼ histone acetyl transferase
HDAC ¼ histone deacetylase
LV ¼ left ventricle
PA ¼ pulmonary artery
RII ¼ receptor type II
RV ¼ right ventricle
SD ¼ standard deviation
SL2 ¼ Schneider’s Drosophila line 2
Sp ¼ specificity protein
TSA ¼ trichostatin A
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Schronic right ventricular outflow tract obstruction. Charac-
terization of the differential transcriptional profiles in right
ventricle (RV) dysfunction resulting from pressure versus
volume loading may have important mechanistic implica-
tions for the identification of relevant biomarkers as well
as the treatment of the RV in congenital heart disease.9
We report an ovine model of RV pressure loading, and
show that Sp3—a zinc finger protein essential for normal
cardiac development—is expressed differentially in volume
versus pressure-loaded RVs and, in turn, may regulate gene
expression differentially during pathologic hypertrophy.METHODS
Reagents, Constructs andReporter Gene Assays, Cell
Culture, Transfection, and Transactivation Assays
Reagents, media, enzymes, and sera for tissue culture were purchased
from the Cell Culture Facility at the University of California (San Fran-
cisco, Calif). Oligonucleotides were purchased from Operon Biotechnol-
ogies, Inc (Alameda, Calif) or Invitrogen (Carlsbad, Calif).
The promoter/reporter constructs used in this study consist of fragments
of the cardiac troponin T promoter and brain natriuretic peptide (BNP) pro-
moter as reported previously.3,4 Luciferase reporter constructs were created
and subcloned into the plasmid pGL2 (Promega, Madison, Wis) as
described described.3,4
Neonatal lamb cardiomyocyte or Schneider’s Drosophila line 2 (SL2)
cell cultures were performed using established standard techniques.3,4
Plasmid constructs were transfected according to the manufacturer’s
protocol (Effectene Transfection Kit; Qiagen, Inc, Valencia, Calif) with
minor modifications. Reporter gene activity was determined using the
dual-luciferase reporter assay (DLR; Promega). Light intensity assays
were read on a luminometer TD-20/20 DLR ready (Turner Designs Instru-
ments, Sunnyvale, Calif). Cotransfection with 20 ng phRL-TK reporter was
used to standardize for transfection variability. Cotransfection efficiency
was verified with pSV-b-galactosidase (Promega) and/or pAAV-GFP stain-
ing. Reporter gene activity was expressed as the mean  the standard de-
viation (SD). Statistical comparisons were performed by paired t tests.
Nuclear Extracts, Western Blot Analysis, and
Densitometry
Cardiac muscle was harvested from 4-week-old lambs (control, shunt,
PA band) at 4C and was prepared by standard methods (Active Motif,
Inc, Carlsbad, Calif).1336 The Journal of Thoracic and Cardiovascular SurTotal protein concentration was quantitated with the Bio-Rad DC pro-
tein assay kit (Bio-Rad Laboratories, Hercules, Calif). An equal amount
of protein was loaded in each lane for Western blots. Sodium dodecylsul-
fate–polyacrylamide gel electrophoresis was used to separate nuclear pro-
teins (10 mg) on a 10% gel andwas followed by transfer to a polyvinylidene
difluoride membrane (Amersham Biosciences, GE Healthcare Bio-
Sciences Corporation, Piscataway, NJ). Membranes were then blocked
and incubated with antibody as described previously.4 Reactive bands
were visualized with the SuperSignal West Femto Maximum Sensitivity
Substrate Kit (Pierce, Rockford, Ill) and Kodak 440CF image station
(Kodak, New Haven, Conn). The image was selected and analyzed with
the public domain program NIH Image, and band intensity was quantified.
Parallel sodium dodecylsulfate gels and immunoblots of b-actin and glyc-
eraldehyde-3-phosphate dehydrogenase controls were performed to verify
sample integrity and loading quantity.
Surgical Preparations and Care: Ewes
Pregnant, mixed-breed Western ewes (gestation range, 135-140 days;
term, 145 days) were operated under sterile conditions. Through a left lat-
eral fetal thoracotomy, an 8.0-mm polytetrafluoroethylene vascular graft
(length, 2 mm; W.L. Gore & Associates, Inc, Flagstaff, Ariz) was sewn be-
tween the ascending aorta and main PA as described previously.10 Pressure
loading of the RV was generated by banding the main PA 75% of its
circumference. All lambs were delivered spontaneously and were instru-
mented as previously described.3,4
Heart Tissue Preparation
Whole heart and chamber-specific weights were measured in all
shunted, banded, and control specimens. Samples of right atrium, RV,
left atrium, left ventricle (LV), and ventricular septum were excised,
weighed, and used to make fresh nuclear preparations. Whole tissue and
nuclear preparations were snap-frozen in liquid nitrogen. Samples were
stored at 70C until used for analysis.
Immunoprecipitation
Right ventricle and LV nuclear extracts were prepared from PA banded
sheep hearts, and an equal amount of protein was used in each experiment.
Nuclear extracts were preincubated with protein A/G-Sepharose for 3
hours at 4C according to the manufacturer’s instructions (Pierce crosslink
IP Kit; Thermo Scientific, Rockford Ill). The beads were collected by
centrifugation at 5000g for 2 minutes at 4C. The supernatants were trans-
ferred to new tubes and were then incubated with either anti-Sp3 or
anti-Sp1 antibodies with rotation overnight at 4C.
Histone Acetyl Transferase and Histone Deacetylase
Activity Assays
The histone acetyl transferase (HAT) activity and inhibition of histone
deacetylase (HDAC) activity was performed using HAT (Enzo Life Sci-
ences, Inc, New York, NY) and HDAC (Upstate Biotechnology, Lake
Placid, NY) colorimetric detection assay kits.gery c May 2013
TABLE 2. Hemodynamics
Shunted Control (n ¼ 5) Shunted (n ¼ 6)
MAP 75  6 70  8
RAP 4.5  2 2.9  0.8
LAP 5.4  2 6.4  3
PAP 17  2 22  2*
PA banded Control (n ¼ 4) Banded (n ¼ 4)
MAP 77  7 66  9
RAP 5.2  2 9.4  5
LAP 4.9  2 5.9  3
PAP 32  16 27  10
RVSP 36  4 96  8*
PROXPA, Sys 38  8 82  13*
DISTALPA, Sys 31  6 27  10
Values are in millimeters of mercury, mean standard deviation.MAP, Mean arterial
pressure; RAP, right atrial pressure; LAP, left atrial pressure; PAP, pulmonary artery
pressure; RVSP, right ventricular systolic pressure; PROXPA, proximal pulmonary ar-
tery pressure; Sys, systolic; DISTALPA, distal pulmonary artery pressure. *P<.05.
Azakie et al Evolving Technology/Basic ScienceFor the HAT assay, 20 mg of nuclear extracts or 200 ng of the Sp1 and
Sp3 immunoprecipitated proteins were plated in 96-well plates and in-
cubated with the reaction substrates for 60 minutes at 37C, followingFIGURE 1. Characteristic Western blots of myocardium from 4-week-old
(B). Expression of sarcomeric myosins and cTnT is upregulated. ANP and BNP,
Sp1, MEF-2, Nkx2.5, and GATA-4 are increased whereas Sp3 expression is e
used for Western blot analysis is shown on the left. RA, Right atrium; RV, ri
TEF, transcriptional enhancer factor; ANP, atrial natriuretic peptide; BNP, brain
PARP, poly-(adenosine diphosphate) ribose polymerase; cTnT, cardiac troponin
The Journal of Thoracic and Carthe manufacturers’ protocols. The reaction mix was analyzed in a plate
reader (Spectramax M2; Molecular Devices, Sunnyvale, Calif). The his-
tone acetyl transferase activity is expressed as the relative absorbance
440 nm OD value. The HDAC Activity Colorimetric Assay kit (Upstate
Biotechnology) was used according to the manufacturer’s protocol.
Briefly, 10 mL (20 mg) of nuclear protein or 200 ng of Sp1 or Sp3 im-
munoprecipitated proteins was diluted in a final volume of 85 mL of
ddH2O and placed in a 96-well plate. A total of 10 mL of the HDAC as-
say substrate was added to each well and was mixed thoroughly. The
mixture was incubated at 37C for 1 hour. A total of 20 mL of the diluted
activator solution was added to each well and was mixed thoroughly,
and the plate was then incubated at room temperature for 20 minutes.
Samples were analyzed in a plate reader (Spectramax M2; Molecular
Devices) at 405 nm. Results are expressed as mean  SD for 4 separate
experiments.
Statistical Analysis
Comparisons between shunt and age-matched controls were made by
appropriate t testing.
All protocols and procedures were approved by the Committee on
Animal Research of the University of California, San Francisco. All
animals were euthanized by appropriate methods as described in the Na-
tional Institutes of Health Guidelines for the Care and Use of Laboratory
Animals.banded lambs versus controls (A) and shunted lambs versus controls
markers of stretch or hypertrophy, are also upregulated. The transactivators
nhanced in banded hearts and repressed in the shunted RV. The antibody
ght ventricle; LA, left atrium; LV, left ventricle; MW, molecular weight;
natriuretic peptide; Sp, specificity protein;MEF, myocyte enhancer factor;
T; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
diovascular Surgery c Volume 145, Number 5 1337
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FIGURE 2. Densitometry of Western blot bands in banded RVs (n ¼ 4) versus controls (n ¼ 4) (A) and shunted RVs (n ¼ 6) versus controls (n ¼ 5) (B).
Relative densitometry is on the vertical axis. Antibody used for control versus banded (A) or shunted (B) specimens is on the horizontal axis. Bar graphs with
variations and P values comparing control with test RVare shown. Actin and GAPDH controls show no difference. Sarcomeric proteins and transcription
factor expression is increased significantly for all tested proteins in the band model, including Sp3. In the shunted RV model, Sp3 expression is reduced
significantly. RV, Right ventricle; PAB, Pulmonary artery banding; TEF, transcriptional enhancer factor; ANP, atrial natriuretic peptide; BNP, brain natri-
uretic peptide; Sp, specificity protein; MEF, myocyte enhancer factor; PARP, poly-(adenosine diphosphate) ribose polymerase; cTnT, cardiac troponin T;
GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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SRESULTS
Pulmonary Artery Banding Produces Right
Ventricular Hypertrophy
Four-week-old lambs that had in utero banding of the
PA showed a significant increase in total cardiac mass
compared with control animals (104  30 g vs 44  5
g, P ¼ .001; Table 1). The increase in total cardiac
mass was comparable with that seen in shunted lambs
of the same age (113  34 g vs 36  7 g, P ¼ .001). Sig-
nificant increases were seen for all chambers and the sep-
tum. The increase in mass of the LV in banded lambs was
not statistically significant (Table 1). Banded animals de-
veloped systemic RV systolic pressures, with a peak sys-
tolic gradient ranging from 25 to 60 mm Hg (Table 2).
The increased RV pressure in banded lambs was signifi-
cantly higher than in controls, the PA pressure proximal
to the band in banded lambs was significantly higher than1338 The Journal of Thoracic and Cardiovascular Surthe proximal PA pressure in controls, and in the PA band
group, the proximal PA pressure was significantly higher
than the PA pressure distal to the band (Table 2). Four-
week-old shunted animals had hemodynamics similar
to our previously published results for 2-week-old
lambs.3,4
Right Ventricle Pressure Overload Results in
Increased Expression of Sarcomeric Proteins and
Myocardial Transcription Factors
Tissue homogenates of myocardium derived from
sheep that had PA banding or aortopulmonary shunt inser-
tion were used for Western blot analysis (Figure 1, A and
B, respectively). In both PA-banded and shunted hearts,
MF-20 was upregulated significantly in the RV. There
was an associated increase in cardiac troponin T expres-
sion in the RVs of both banded and shunted lambs. Thegery c May 2013
FIGURE 2. (continued).
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Supregulation of cTnT expression was associated with ex-
pression of high-molecular weight isoforms, which char-
acterize the early fetal program. Relevant cardiac
transcription factors, including GATA-4, transcriptional
enhancer factor 5, atrial natriuretic peptide, BNP, myo-
cyte enhancer factor 2, poly-(adenosine diphosphate) ri-
bose polymerase, Nkx2.5, and Sp1, were all upregulated
in the ventricles of both shunted and banded lambs. In
the shunted animals, Sp3 expression in the RV was sup-
pressed; in contrast, the expression of Sp3 in banded
sheep hearts was significantly increased. Quantitative
analysis of sarcomeric protein and myocardial transcrip-
tion factor expression is summarized in Figure 2. Relative
band densitometry was performed to compare expression
levels quantitatively (banded, n ¼ 4; controls, n ¼ 4).
Densitometric analysis confirms that the upregulation in
sarcomeric protein and transcription factor levels in the
RVs of PA-banded (Figure 2, A) and shunted lambs
(Figure 2, B) compared with controls was statistically sig-
nificant. There was no significant difference in actin or
glyceraldehyde 3-phosphate dehydrogenase expression
levels in shunted or banded versus control RVs. By den-
sitometry, Sp3 levels were significantly lower in shunted
RVs compared with controls, and were upregulated sig-
nificantly in banded RVs compared with controls.The Journal of Thoracic and CarSp3 is Upregulated and Acetylated, and
Demonstrates Increased Promoter Binding in the RV
Subject to Pressure Loading
We postulated that Sp3may undergo the posttranslational
modification of acetylation. Sp3 expression and acetylation
in the shunted RV is repressed. Nuclear protein from the RV
of 4-week-old PA-banded and control lambs were immuno-
precipitated with Sp3 and then run on a Western blot.
Screening of the Western blots with either Sp3 or pan-
acetyl antibody confirmed that Sp3 expression and acetyla-
tion were upregulated in the RV of banded animals
(Figure 3, A). Furthermore, lower molecular weight iso-
forms of Sp3 were translated in banded RVs. Relative
band densitometry confirmed that the differences in expres-
sion and acetylation of Sp3 in banded RVs compared with
controls are significant (Figure 3, B). We sought to deter-
mine the interactions between Sp3 and histone acetylating
and deacetylating nuclear proteins in control and banded
RVs (Figure 3, C). Immunoprecipitates of Sp3 derived
from RV nuclear extracts from banded and control lambs
were analyzed by colorimetry. The interaction of Sp3
with HAT was upregulated significantly in the RVs of
banded versus control lambs. Sp3 association with HDAC
was diminished significantly in the RV of banded lambs
compared with controls.diovascular Surgery c Volume 145, Number 5 1339
FIGURE 3. A, Nuclear protein derived from control or banded (PAB) lambmyocardium that is immunoprecipitated with Sp3was screened byWestern blot
analysis using antibody to Sp3 or acetyl groups. Sp3 expression is increased in banded hearts; lowermolecular weight (MW) isoforms are also translated. The
degree of acetylation of Sp3 in RVs is increased. Antibody is listed on the left. Nucleoporin p62 is the control antibody. B, Bar graphs of densitometric
analysis of Western blots shown in (A) (banded, n ¼ 4; controls, n ¼ 4). C and D Immunoprecipitates of cardiac nuclear protein using Sp3 antibody
were assayed for associated histone acetyl transferase (C) or HDAC (D) activity. Histone acetyl transferase activity associated with Sp3 is upregulated
Evolving Technology/Basic Science Azakie et al
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FIGURE 3. (continued).
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SHaving determined that Sp3 expression and acetyla-
tion of Sp3 is increased in the RVs, we sought to deter-
mine whether Sp3 binding to cardiac promoters changed
with pressure loading. Chromatin immunoprecipitation
of the cardiac troponin T and BNP promoters was per-
formed with Sp3 antibody. Figure 4 shows that the
Sp3 nuclear protein has qualitatively increased binding
to the BNP and cTnT promoter in the RV of banded
hearts (n ¼ 4) compared with controls (n ¼ 4). By rel-
ative band densitometry, Sp3 binding affinity to the
cTnT promoter more than doubled in the RVs of banded
hearts (818  49 relative OD units [banded] vs 405  84
OD units [control]; n ¼ 4 each, P ¼ .005). Although the
increase in binding of Sp3 to the BNP promoter in
banded RVs was increased slightly (609  45 relative
OD units [control] vs 708  20 relative OD units [PA
banded]; n ¼ 4, P ¼ .002), the difference was
significant.
To determine the transactivating effects of Sp3, we
performed transient transfections of the luciferase re-
porter gene driven by the cardiac troponin T promoter
in primary cultures of SL2 cells that lack endogenous
Sp factors (Figure 5). The baseline activity of the
268cTnT promoter is repressed by cotransfection of
Sp3 expression constructs. Western blots of cell lysates
of cultured SL2 cells transfected with Sp3 expression
constructs confirm that the Sp3 protein is translated. Ad-
dition of trichostatin A (TSA), an HDAC inhibitor, tosignificantly in banded lambs (C) whereas HDAC association with Sp3 is reduce
PAB, Pulmonary artery banding; HDAC, histone deacetylase; RV, right ventricle
ferase; Sp, specificity protein.
The Journal of Thoracic and CarSL2 cells cotransfected with cTnT reporter constructs
and Sp3 expression vectors results in acetylation of
Sp3 in the SL2 system. 268cTnT Promoter activity is
superactivated significantly to levels beyond the superac-
tivating effects of TSA alone. By mutational analysis,
the activating effects of acetylated Sp3 are dependent
on an intact, wild-type GC box—the cTnT promoter
binding site for Sp factors. Mutation of the GC box led
to substantial reduction of promoter activity that was
not responsive to cotransfection of Sp1 or Sp3, or the ad-
dition of TSA.
DISCUSSION
In the current study, we report an ovinemodel of RV pres-
sure loading by in utero PA banding. The RV in this model
develops significant hypertrophy, increased mass, regres-
sion to the fetal cardiac gene program, and upregulation
of cardiac myosins and markers of hypertrophy (BNP).
Cardiac muscle transcription factors (myocyte enhancer
factor 2, Nkx2.5, GATA-4, transcriptional enhancer factors,
and Sp1) known to regulate cardiac differentiation and de-
velopment are upregulated in a way comparable with that
seen in shunted ventricles.3,4 Sp3, a transcriptional
repressor, is regulated differentially. It is downregulated in
volume-loaded ventricles, and paradoxically upregulated
in pressure-loaded ventricles where it is also converted to
a transactivator through the posttranslational modification
of acetylation. The differential responses of the RV tod significantly in banded RVs (n¼ 4) compared with controls (n ¼ 4) (D).
; LV, left ventricle; Hela, Hela nuclear extracts; HAT, histone acetyl trans-
diovascular Surgery c Volume 145, Number 5 1341
FIGURE 4. Sp3 binding to cTnTand BNP promoters is enhanced in the RVafter pulmonary artery banding. Chromatin immunoprecipitation from control
or banded (PAB) lamb right and left ventricles. DNA prepared from ventricular chromatin (input DNA) was complexed using Sp3 and eluted (output DNA).
Input DNA and CHIP output DNAwere used for polymerase chain reactions (PCRs) using primers specific for the BNP and cTnT promoters. Promoter
segments derived from PCR are labeled on the left. RV, Right ventricle; LV, left ventricle; PAB, pulmonary artery banding; Ab, antibody; BNP, brain natri-
uretic peptide; cTnT, cardiac troponin T.
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Svolume versus pressure load may, in part, be regulated by
Sp3 transactivation pathways. Sp3 may serve as a clinical
biomarker for differential RV responses to variable loading
conditions, a prognostic indicator of severity or type of RV
dysfunction, or may represent an important transcriptional
pathway for targeted pharmacotherapy of heart failure.
Bartelds and colleagues9 recently reported on the differ-
ential responses of the RV to variable loading conditions in
a murine model. Right ventricle pressure loading was cre-
ated by PA banding whereas volume overload was gener-
ated by aortocaval shunts. Pressure load appeared to be
more harmful than volume loading because RV failureFIGURE 5. Reporter gene activity driven by 268cTnT promoter constructs
promoter activity (lane 1) is enhanced by Sp1 (lane 5) but repressed by Sp3
(lane 11). Addition of TSA results in increased baseline promoter activity (lane
of TSA, Sp3 switches from a repressor to an activator and enhances promoter ac
mediated superactivation (lane 11) of the promoter is reversed with the addition
pendent on the GC box, which when mutated results in significant depression of
9, and 10). Western blots of all lysates confirm that Sp1 and Sp3 are expressed w
culture (data not shown). GC-mut, Mutated GC box in 268cTnT promoter; TK,
relative light unit; cTnT, cardiac troponin T; Sp, specificity protein.
1342 The Journal of Thoracic and Cardiovascular Surdeveloped more rapidly. They postulate that, in addition
to the hemodynamic and pathophysiologic differences, the
type of loading may also induce different molecular signal-
ing patterns that define the RV response and dysfunction.
We propose that Sp3 may play an important role in the mal-
adaptive, differential responses of RVs to abnormal or vari-
able loading conditions. Sp3 is required for normal cardiac
development and plays a critical role in myocardial differ-
entiation. Mice lacking the zinc finger transcription factor
Sp3 die in utero. Sp3 null hearts have defective looping
and develop severe cardiac malformations. We have shown
previously that Sp3 inhibits cardiac promoter activity andtransfected in cultured SL2 cells that lack endogenous Sp1/Sp3. Baseline
(lane 7). Sp3 also inhibits Sp1-mediated superactivation of the promoter
2), as well as Sp1-mediated promoter activation (lane 6). In the presence
tivity (lane 8) to levels greater than with TSA alone. Sp3 repression of Sp1-
of TSA (lane 12). TSA and Sp1/Sp3 effects are mediated through and de-
promoter activity despite the addition of coactivators (Sp1, TSA; lanes 3, 4,
hen transfected into SL2 cells, and are acetylated when TSA is added to the
thymidine kinase; TSA, trichostatin A, histone deacetylase inhibitor; RLU,
gery c May 2013
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In the volume-loaded heart, inhibitory Sp3 is downregu-
lated, consistent with derepression of the pathologic hyper-
trophic program. Sp3 is expressed differentially in the
pressure-loaded RV, where it is paradoxically upregulated.
The differential regulation of Sp3 may have mechanistic
implications for the differential response of the RV to vari-
able, abnormal loading conditions. Braun and associates11
have shown that Sp3 is regulated by acetylation, the impli-
cations of which may explain is dual role in promoter inhi-
bition versus Activation. During pressure loading, the
interaction of Sp3 with HAT is upregulated whereas interac-
tion with HDACs is diminished, favoring modification of
the protein by acetylation. Acetylated Sp3 is a transcrip-
tional activator. We show that acetylation of Sp3 with
TSA results in superactivation of the cTnT promoter and
that the effect is dependent on the GC box found in the prox-
imal portion of the cTnT promoter. We have shown previ-
ously that the GC box is a binding site for the Sp family
of nuclear proteins and is essential for cTnTactivity.4 These
findings are consistent with the report from Ammanaman-
chi and coworkers,12 which showed that the HDAC inhibi-
tor TSA induces acetylation of Sp3, which acts as
a transcriptional activator of transforming growth factor-
b receptor type II (RII). Promoter mutational analysis indi-
cated the TSA response is mediated through a GC box
located on the RII promoter, which was identified previ-
ously as an Sp1/Sp3-binding site that was critical for RII
promoter activity.12
Chromatin remodeling is an importantmechanismof tran-
scriptional regulation. Histone acetylation results in decon-
densation of chromatin, transforming it into a loosely
organized structure. Relaxed chromatin allows for exposure
of gene promoters and transcriptional activation, and can be
brought about by inhibition of HDAC or activation of HAT.
Conversely, deacetylation of chromatin transforms it into
a less transcriptionally active, tightly packed structure.
Widespread inhibition of HDACs does not always
induce sweeping transactivation of gene promoters.13,14
Trichostatin A may induce an initial, brief increase
in histone acetylation, chromatin loosening, and
transcriptional activation; however, hyperacetylation is
often a transient phenomenon. The addition of the HDAC
inhibitor TSA to SL2 cells in culture transfected with the
cTnT promoter constructs resulted in increased promoter
activity. In the presence of TSA, cotransfection of Sp3 did
not suppress promoter activity, but further enhanced both
baseline and Sp1-mediated promoter activation of reporter
gene expression. The effect may not only be a result of the
conversion of Sp3 to an activator by acetylation, but also
may relate to enhanced recruitment and binding of Sp3 and
Sp1 to promoter sites as shown by chromatin immunoprecip-
itation.The ability of Sp factors tomediate the effects of TSA
has been shown in a number of other systems including bcl-2,The Journal of Thoracic and CarNaþ/Hþ exchange andp21genes.15-17Hence,TSA-induced
activation of the cTnT promotermay extend beyond acetyla-
tion of chromatin or transcription factors, and include en-
hanced recruitment of Sp factors (and probably ribonucleic
acid polymerase II) to target gene promoters.13
The RV is different phylogenetically and ontogenetically
from the LV, having different embryologic origins, and dis-
tinct physiologic and structural characteristics. Preliminary
data in the ovine model, however, suggest that the LV re-
sponse to pressure versus volume loading is regulated in
a manner similar to the RV. We have generated an animal
model of supravalvar aortic stenosis and LV pressure loading
in lambs. The regulation of Sp3 expression and acetylation
patterns is similar to that seen in the RV, inferring a basic
role for Sp3 in the maladaptive responses of cardiac muscle
in general. Further characterization of the LV transcriptional
response to abnormal loading conditions in ovine models is
in progress. Models that use banding (or shunting) in very
late gestation represent an acute pressure/volume load
shortly prior to birth that has limitations in terms of extrapo-
lating the data to congenital heart defects in which the hemo-
dynamic lesion may be present through most of gestation.
Future areas of investigation will also include the character-
ization of the transcriptional response to other clinically rel-
evant conditions such asmilder forms of PS, or combined PS
and PI, and the therapeutic effects of TSA and other HDAC
inhibitors on maladaptive myocardial hypertrophy.References
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